# Morphine for Dyspnea in Pulmonary Fibrosis

> **NCT04497831** · PHASE3 · UNKNOWN · sponsor: **Medical University of Gdansk** · enrollment: 20 (estimated)

## Conditions studied

- Idiopathic Pulmonary Fibrosis (IPF)

## Interventions

- **DRUG:** Morphine hydrochloride
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04497831
- **Lead sponsor:** Medical University of Gdansk
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-09-21
- **Primary completion:** 2022-09-21
- **Final completion:** 2022-09-21
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2020-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04497831

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04497831, "Morphine for Dyspnea in Pulmonary Fibrosis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04497831. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*